These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21350422)

  • 1. [Neuromidin in mixed vascular and Alzheimer's dementia].
    Damulin IV; Stepkina DA; Lokshina AB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2):40-3. PubMed ID: 21350422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of reminyl (galantamine) in the treatment of dementia].
    Voronkova KV; Pylaeva OA; Mazal'skaia OV; Lemeshko ID; Petrukhin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(3):26-30. PubMed ID: 16608108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of neuromidin in patients with minor ischemic stroke].
    Maksimova MIu; Sharov MN; Sineva NA; Vodop'ianov NP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 2):35-40. PubMed ID: 22224243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of neuromidin in alcoholic encephalopathy].
    Barantsevich ER; Posokhina OV; Smirnova AIu; Kurashevich KG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(3):49-53. PubMed ID: 21423115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial.
    Erkinjuntti T; Kurz A; Gauthier S; Bullock R; Lilienfeld S; Damaraju CV
    Lancet; 2002 Apr; 359(9314):1283-90. PubMed ID: 11965273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Galantamine (reminyl) in the treatment of Alzheimer's disease and vascular dementia].
    Gavrilova SI; Zharikov GA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(12):59-65. PubMed ID: 14763262
    [No Abstract]   [Full Text] [Related]  

  • 7. [The treatment of Alzheimer's disease in patients with comorbid somatic pathology].
    Selezneva ND; Gavrilova SI; Kalyn IaB; Kolykhalov IV; Fedorova IaB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(7):35-42. PubMed ID: 18833116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of galantamine in Alzheimer's disease associated with vascular dementia (according to the study of T. Erkinjuntti group)].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):65-7. PubMed ID: 19938276
    [No Abstract]   [Full Text] [Related]  

  • 9. [Neuromidin in the treatment of vascular cognitive disorders].
    Golovkova MS; Zakharov VV; Lifshits MIu; Iakhno NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):20-6. PubMed ID: 18379458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galantamine: a review of its use in Alzheimer's disease and vascular dementia.
    Corey-Bloom J
    Int J Clin Pract; 2003 Apr; 57(3):219-23. PubMed ID: 12723727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D
    Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial.
    Kertesz A
    Curr Neurol Neurosci Rep; 2002 Nov; 2(6):503-4. PubMed ID: 12359103
    [No Abstract]   [Full Text] [Related]  

  • 13. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
    Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
    Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galantamine: use in Alzheimer's disease and related disorders.
    Bullock R
    Expert Rev Neurother; 2004 Mar; 4(2):153-63. PubMed ID: 15853556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of ipidacrinum (neuromidin) in mononeuropathies].
    Bel'skaia GN; Popov DV; Gusev VV; Tikhomirova IN; Lukashevich IG; L'vova OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10):31-2. PubMed ID: 23250595
    [No Abstract]   [Full Text] [Related]  

  • 16. Rivastigmine for subcortical vascular dementia.
    Román GC
    Expert Rev Neurother; 2005 May; 5(3):309-13. PubMed ID: 15938663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of galantamine on vasomotor reactivity in Alzheimer's disease and vascular dementia due to cerebral microangiopathy.
    Bär KJ; Boettger MK; Seidler N; Mentzel HJ; Terborg C; Sauer H
    Stroke; 2007 Dec; 38(12):3186-92. PubMed ID: 17962592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors.
    Erkinjuntti T; Román G; Gauthier S
    Neurol Res; 2004 Jul; 26(5):603-5. PubMed ID: 15265282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholesterol inhibitor and memantine in symptomatic dementia therapy].
    Rodda J; Carter J
    Praxis (Bern 1994); 2013 Feb; 102(5):293-300; discussion 298-9. PubMed ID: 23446240
    [No Abstract]   [Full Text] [Related]  

  • 20. The long-term efficacy and tolerability of donepezil in patients with vascular dementia.
    Wilkinson D; Róman G; Salloway S; Hecker J; Boundy K; Kumar D; Posner H; Schindler R
    Int J Geriatr Psychiatry; 2010 Mar; 25(3):305-13. PubMed ID: 19623601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.